These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 109782)

  • 1. Diamine oxidase activity in plasma and urine in uremia.
    Tam CF; Kopple JD; Wang M; Swendseid ME
    Nephron; 1979; 23(1):23-7. PubMed ID: 109782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diamine oxidase in renal failure.
    Kopple JD; Tam CF; Wang M; Swendseid ME
    Kidney Int Suppl; 1978 Jun; (8):S20-5. PubMed ID: 99597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid metabolism in the chronically uremic rat.
    Swendseid ME; Wang M; Vyhmeister I; Chan W; Siassi F; Tam CF; Kopple JD
    Clin Nephrol; 1975 Jun; 3(6):240-6. PubMed ID: 237643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced postheparin plasma diamine oxidase activity in patients with chronic renal failure.
    Stein J; Scheuermann EH; Yazdi R; Lembcke B; Caspary WF
    Z Gastroenterol; 1994 Apr; 32(4):236-9. PubMed ID: 8017098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.
    Kopple JD; Gordon SI; Wang M; Swendseid ME
    J Lab Clin Med; 1977 Aug; 90(2):303-11. PubMed ID: 886215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine and diamine oxidase activities in uremic rats.
    Wang M; Tam CF; Swendseid ME; Kopple JD
    Life Sci; 1975 Aug; 17(4):653-8. PubMed ID: 810633
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
    Kario K; Matsuo T; Yamada T; Matsuo M
    Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.
    Ibels SL; Reardon MF; Nestel PJ
    J Lab Clin Med; 1976 Apr; 87(4):648-58. PubMed ID: 775004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diamine oxidase content in urine of patients with renal failure.
    Giarnieri D; Costa MT; Giarnieri V; Mondovi B
    Agents Actions; 1985 Apr; 16(3-4):249-51. PubMed ID: 3925735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased plasma postheparin diamine oxidase levels in celiac disease.
    Corazza GR; Falasca A; Strocchi A; Rossi CA; Gasbarrini G
    Dig Dis Sci; 1988 Aug; 33(8):956-61. PubMed ID: 3134178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of serum semicarbazide-sensitive amine oxidase activity in chronic renal failure.
    Nemcsik J; Szökö E; Soltész Z; Fodor E; Toth L; Egresits J; Tábi T; Magyar K; Kiss I
    J Neural Transm (Vienna); 2007; 114(6):841-3. PubMed ID: 17431736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of in vivo and in vitro dialysis on plasma transaminase activity.
    Crawford DR; Reyna RS; Weiner MW
    Nephron; 1978; 22(4-6):418-22. PubMed ID: 740106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variations in prolactinemia in 26 uremic subjects treated by periodic hemodialysis].
    Deambrogio P; Vanni M; Aleo AG
    Minerva Med; 1985 Apr; 76(17-18):847-9. PubMed ID: 4000528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylalanine metabolism in uremic and normal man.
    Jones MR; Kopple JD; Swendseid ME
    Kidney Int; 1978 Aug; 14(2):169-79. PubMed ID: 357810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse.
    Hilsden RJ; Meddings JB; Hardin J; Gall DG; Sutherland LR
    Inflamm Bowel Dis; 1999 May; 5(2):85-91. PubMed ID: 10338376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic fate of plasma diamine oxidase: evidence of isolated and perfused rat liver uptake.
    D'Agostino L; Ciacci C; Capuano G; Daniele B; D'Argenio G; Barone MV; Rodinò S; Budillon G; Mazzacca G
    Digestion; 1986; 34(4):243-50. PubMed ID: 3091435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effect of hemodialysis and peritoneal dialysis on the inhibition of in vitro calcification by uremic serum.
    Oreopoulos DG; Pitel S; Husdan H; de Veber GA; Rapoport A
    Can Med Assoc J; 1974 Jan; 110(1):43-7. PubMed ID: 4809445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
    Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
    Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
    [No Abstract]   [Full Text] [Related]  

  • 20. Significant increase of IQ-type heterocyclic amines, dietary carcinogens in the plasma of patients with uremia just before induction of hemodialysis treatment.
    Yanagisawa H; Wada O
    Nephron; 1989; 52(1):6-10. PubMed ID: 2710268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.